ID   AT2L2_HUMAN             Reviewed;         450 AA.
AC   Q8IUZ5; A8K7P6; B3KN36; D3DWP9; Q8WYS6; Q96HW8;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   18-JUN-2025, entry version 181.
DE   RecName: Full=5-phosphohydroxy-L-lysine phospho-lyase;
DE            EC=4.2.3.134 {ECO:0000269|PubMed:22241472};
DE   AltName: Full=Alanine--glyoxylate aminotransferase 2-like 2;
GN   Name=PHYKPL; Synonyms=AGXT2L2 {ECO:0000303|PubMed:22241472};
GN   ORFNames=PP9286;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   VAL-437.
RC   TISSUE=Placenta, and Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Muscle, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22241472; DOI=10.1074/jbc.m111.323485;
RA   Veiga-da-Cunha M., Hadi F., Balligand T., Stroobant V., Van Schaftingen E.;
RT   "Molecular identification of hydroxylysine kinase and of
RT   ammoniophospholyases acting on 5-phosphohydroxy-L-lysine and
RT   phosphoethanolamine.";
RL   J. Biol. Chem. 287:7246-7255(2012).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANTS PHLU ARG-240 AND VAL-437.
RX   PubMed=23242558; DOI=10.1007/s10545-012-9568-9;
RA   Veiga-da-Cunha M., Verhoeven-Duif N.M., de Koning T.J., Duran M.,
RA   Dorland B., Van Schaftingen E.;
RT   "Mutations in the AGXT2L2 gene cause phosphohydroxylysinuria.";
RL   J. Inherit. Metab. Dis. 36:961-966(2013).
CC   -!- FUNCTION: Catalyzes the pyridoxal-phosphate-dependent breakdown of 5-
CC       phosphohydroxy-L-lysine, converting it to ammonia, inorganic phosphate
CC       and 2-aminoadipate semialdehyde. {ECO:0000269|PubMed:22241472}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5R)-5-phosphooxy-L-lysine + H2O = (S)-2-amino-6-oxohexanoate
CC         + NH4(+) + phosphate; Xref=Rhea:RHEA:34091, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:43474, ChEBI:CHEBI:57882,
CC         ChEBI:CHEBI:58321; EC=4.2.3.134;
CC         Evidence={ECO:0000269|PubMed:22241472};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:22241472};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=16 uM for 5-phosphohydroxy-L-lysine (at 30 degrees Celsius)
CC         {ECO:0000269|PubMed:22241472};
CC         Vmax=256 nmol/min/mg enzyme {ECO:0000269|PubMed:22241472};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:P22256}.
CC   -!- INTERACTION:
CC       Q8IUZ5; Q8N448: LNX2; NbExp=3; IntAct=EBI-751947, EBI-2340947;
CC       Q8IUZ5; Q8IUZ5: PHYKPL; NbExp=6; IntAct=EBI-751947, EBI-751947;
CC       Q8IUZ5; Q9NUX5: POT1; NbExp=2; IntAct=EBI-751947, EBI-752420;
CC       Q8IUZ5; O60763: USO1; NbExp=3; IntAct=EBI-751947, EBI-356164;
CC       Q8IUZ5; Q08AM6: VAC14; NbExp=4; IntAct=EBI-751947, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305|PubMed:22241472}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IUZ5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IUZ5-2; Sequence=VSP_025585;
CC       Name=3;
CC         IsoId=Q8IUZ5-3; Sequence=VSP_025584;
CC   -!- DISEASE: Phosphohydroxylysinuria (PHLU) [MIM:615011]: A condition
CC       characterized by elevated phosphohydroxylysine in the urine. There is
CC       no clinical phenotype associated with this finding other than the
CC       urinary metabolites. {ECO:0000269|PubMed:23242558}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -!- CAUTION: Does not seem to possess aminotransferase activity.
CC       {ECO:0000305|PubMed:22241472}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF318375; AAL55882.1; -; mRNA.
DR   EMBL; AK023470; BAG51198.1; -; mRNA.
DR   EMBL; AK292061; BAF84750.1; -; mRNA.
DR   EMBL; AC136601; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471165; EAW53836.1; -; Genomic_DNA.
DR   EMBL; CH471165; EAW53841.1; -; Genomic_DNA.
DR   EMBL; BC008009; AAH08009.1; -; mRNA.
DR   EMBL; BC037567; AAH37567.1; -; mRNA.
DR   EMBL; BC110335; AAI10336.1; -; mRNA.
DR   CCDS; CCDS4434.1; -. [Q8IUZ5-1]
DR   RefSeq; NP_001265275.1; NM_001278346.1.
DR   RefSeq; NP_699204.1; NM_153373.4. [Q8IUZ5-1]
DR   AlphaFoldDB; Q8IUZ5; -.
DR   SMR; Q8IUZ5; -.
DR   BioGRID; 124425; 18.
DR   FunCoup; Q8IUZ5; 521.
DR   IntAct; Q8IUZ5; 11.
DR   STRING; 9606.ENSP00000310978; -.
DR   DrugBank; DB00160; Alanine.
DR   DrugBank; DB00114; Pyridoxal phosphate.
DR   iPTMnet; Q8IUZ5; -.
DR   PhosphoSitePlus; Q8IUZ5; -.
DR   BioMuta; PHYKPL; -.
DR   DMDM; 74750645; -.
DR   jPOST; Q8IUZ5; -.
DR   MassIVE; Q8IUZ5; -.
DR   PaxDb; 9606-ENSP00000310978; -.
DR   PeptideAtlas; Q8IUZ5; -.
DR   ProteomicsDB; 70633; -. [Q8IUZ5-1]
DR   ProteomicsDB; 70634; -. [Q8IUZ5-2]
DR   ProteomicsDB; 70635; -. [Q8IUZ5-3]
DR   Antibodypedia; 29429; 149 antibodies from 26 providers.
DR   DNASU; 85007; -.
DR   Ensembl; ENST00000308158.10; ENSP00000310978.5; ENSG00000175309.15. [Q8IUZ5-1]
DR   GeneID; 85007; -.
DR   KEGG; hsa:85007; -.
DR   MANE-Select; ENST00000308158.10; ENSP00000310978.5; NM_153373.4; NP_699204.1.
DR   UCSC; uc003miz.5; human. [Q8IUZ5-1]
DR   AGR; HGNC:28249; -.
DR   CTD; 85007; -.
DR   DisGeNET; 85007; -.
DR   GeneCards; PHYKPL; -.
DR   HGNC; HGNC:28249; PHYKPL.
DR   HPA; ENSG00000175309; Low tissue specificity.
DR   MalaCards; PHYKPL; -.
DR   MIM; 614683; gene.
DR   MIM; 615011; phenotype.
DR   neXtProt; NX_Q8IUZ5; -.
DR   OpenTargets; ENSG00000175309; -.
DR   PharmGKB; PA162376015; -.
DR   VEuPathDB; HostDB:ENSG00000175309; -.
DR   eggNOG; KOG1403; Eukaryota.
DR   GeneTree; ENSGT00940000159222; -.
DR   HOGENOM; CLU_016922_8_0_1; -.
DR   InParanoid; Q8IUZ5; -.
DR   OMA; REGLNQH; -.
DR   OrthoDB; 10261433at2759; -.
DR   PAN-GO; Q8IUZ5; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q8IUZ5; -.
DR   TreeFam; TF320468; -.
DR   BRENDA; 4.2.3.134; 2681.
DR   PathwayCommons; Q8IUZ5; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-71064; Lysine catabolism.
DR   SABIO-RK; Q8IUZ5; -.
DR   SignaLink; Q8IUZ5; -.
DR   BioGRID-ORCS; 85007; 9 hits in 1120 CRISPR screens.
DR   ChiTaRS; PHYKPL; human.
DR   GenomeRNAi; 85007; -.
DR   Pharos; Q8IUZ5; Tbio.
DR   PRO; PR:Q8IUZ5; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q8IUZ5; protein.
DR   Bgee; ENSG00000175309; Expressed in pancreatic ductal cell and 180 other cell types or tissues.
DR   ExpressionAtlas; Q8IUZ5; baseline and differential.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008483; F:transaminase activity; IEA:InterPro.
DR   CDD; cd00610; OAT_like; 1.
DR   FunFam; 3.40.640.10:FF:000058; ethanolamine-phosphate phospho-lyase isoform X1; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR049704; Aminotrans_3_PPA_site.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR45688; -; 1.
DR   PANTHER; PTHR45688:SF6; 5-PHOSPHOHYDROXY-L-LYSINE PHOSPHO-LYASE; 1.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   PIRSF; PIRSF000521; Transaminase_4ab_Lys_Orn; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Lyase; Mitochondrion;
KW   Proteomics identification; Pyridoxal phosphate; Reference proteome.
FT   CHAIN           1..450
FT                   /note="5-phosphohydroxy-L-lysine phospho-lyase"
FT                   /id="PRO_0000287667"
FT   MOD_RES         278
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P22256"
FT   VAR_SEQ         1..343
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15498874"
FT                   /id="VSP_025585"
FT   VAR_SEQ         1..275
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_025584"
FT   VARIANT         126
FT                   /note="H -> R (in dbSNP:rs7707147)"
FT                   /id="VAR_048233"
FT   VARIANT         240
FT                   /note="G -> R (in PHLU; dbSNP:rs201105857)"
FT                   /evidence="ECO:0000269|PubMed:23242558"
FT                   /id="VAR_069543"
FT   VARIANT         437
FT                   /note="E -> V (in PHLU; dbSNP:rs142181517)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:23242558"
FT                   /id="VAR_069544"
SQ   SEQUENCE   450 AA;  49711 MW;  5EB28A6BDD44C429 CRC64;
     MAADQRPKAD TLALRQRLIS SSCRLFFPED PVKIVRAQGQ YMYDEQGAEY IDCISNVAHV
     GHCHPLVVQA AHEQNQVLNT NSRYLHDNIV DYAQRLSETL PEQLCVFYFL NSGSEANDLA
     LRLARHYTGH QDVVVLDHAY HGHLSSLIDI SPYKFRNLDG QKEWVHVAPL PDTYRGPYRE
     DHPNPAMAYA NEVKRVVSSA QEKGRKIAAF FAESLPSVGG QIIPPAGYFS QVAEHIRKAG
     GVFVADEIQV GFGRVGKHFW AFQLQGKDFV PDIVTMGKSI GNGHPVACVA ATQPVARAFE
     ATGVEYFNTF GGSPVSCAVG LAVLNVLEKE QLQDHATSVG SFLMQLLGQQ KIKHPIVGDV
     RGVGLFIGVD LIKDEATRTP ATEEAAYLVS RLKENYVLLS TDGPGRNILK FKPPMCFSLD
     NARQVVAKLD AILTDMEEKV RSCETLRLQP
//
